Date of publication: January 16,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/FR/06/01/11
Member State: France
Date of Acknowledgement: 12/12/2005
Title of the Project:
Application for the deliberate release of genetically
modified 59122x1507xNK603 (DAS-59122-7xDAS-Ø15Ø7-1xMON-ØØ6Ø3-6)
maize
Proposed period of release From:01/04/2005
To:31/12/2009
Name of the Institute(s) or Company(ies): Pioneer
Genetique;
3. Is the same GMPt release planned elsewhere in the
Community?
No
4 - Has the same GMPt been notified elsewhere by the same
notifier?
No
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
|
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
| maize
|
poaceae |
zea
|
zea
mays |
mays
|
experimental varieties |
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
The genetically modified 59122x1507xNK603 maize varieties
that will be tested in these field trials are resistant to
certain Coleopteran insects, such as Western corn rootworm
(Diabrotica virgifera virgifera), and certain Lepidopteran
insects, such as European corn borer (Ostrinia nubilalis), and
tolerant to glufosinate-ammonium and glyphosate herbicides. This
maize was derived through traditional breeding methods between
progeny of the genetically modified 59122 maize, 1507 maize and
NK603 maize (from Monsanto).
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
The genes introduced in 59122x1507xNK603 maize are the
cry34Ab1 and cry35Ab1 genes from Bacillus thuringiensis strain
PS149B1, providing resistance to certain Coleopteran insects and
the pat gene from Streptomyces viridochromogenes, introduced as
a selectable marker, providing tolerance to glufosinate
herbicide, like 59122 maize, the cry1F gene from Bacillus
thuringiensis var. aizawai, providing resistance to certain
Lepidopteran insects and the pat gene from Streptomyces
viridochromogenes, introduced as a selectable marker, providing
tolerance to glufosinate-ammonium herbicide, like in 1507 maize,
and the cp4epsps gene from Agrobacterium sp. strain CP4 that
confers tolerance to glyphosate herbicide, like in NK603 maize,
along with their regulatory components necessary for expression
in maize plant:
- the cry34Ab1 gene, the UBIZM1(2) promoter, the PINII
terminator.
- the cry35Ab1 gene, the Peroxidase promoter, the PINII
terminator.
- the pat gene, the CaMV35S promoter, the CaMV35S terminator.
- the cry1F gene, the UBIZM1(2) promoter, the ORF25PolyA
terminator.
- the pat gene, the CaMV35S promoter, the CaMV35S terminator.
- the cp4epsps gene, the P-ract1/ract1 intron + ctp2, the NOS 3’
terminator.
- the cp4epsps gene, the CaMV e35S promoter + Zmhsp70 + ctp2,
the NOS 3’ terminator.
6. Brief description of the method used for the genetic
modification:
No genetic modification was made on the 59122x1507xNK603
maize varieties directly: they were derived through traditional
breeding methods between progeny of the genetically modified
59122, 1507 and NK603 maize.
59122 maize was genetically modified using Agrobacterium
transformation method. 1507 maize was genetically modified using
a particle acceleration method. NK603 maize was genetically
modified by Monsanto using a particle acceleration method.
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Not applicable.
Experimental
Release
1. Purpose of the release:
The purpose of the release is to collect additional data on
59122x1507xNK603 maize. Studies will be carried out to observe
the plant behavior, the herbicide application effects, the
control of maize volunteers with different herbicides and the
expression of the genes introduced.
2. Geographical location of the site:
The releases are planned at several locations in France
within the following areas:
Nord-Pas-de-Calais (Nord), Picardie (Aisne, Oise, Somme),
Bourgogne (Saône et Loire), Rhône-Alpes (Ain, Isère, Drome),
Centre (Eure et Loir, Loir et Cher, Indre, Indre et Loire,
Loiret), Aquitaine (Landes, Lot et Garonne), Midi-Pyrénées
(Haute-Garonne, Gers, Tarn, Tarn et Garonne),
Languedoc-Roussillon (Aude).
3. Size of the site (m2):
Every year, there could have up to 12 sites of release, each
sown with up to 5000 m² of genetically modified 59122x1507xNK603
maize subject of this notification. Other genetically modified
maize may be planted on the same sites of release. Thus, the
total trial surface for each site (all varieties and borders
included) will be larger.
In the case of the trials that will be carried out to evaluate
the control of transgenic maize with different herbicides, two
plantings are planned each year, to simulate maize volunteers
that may occur in spring and fall rotational crops.
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Many field trials have already been conducted at several
locations across maize growing regions in North America, South
America and Europe and no environmental problems were reported
for these trials. The transgenic plants were indistinguishable
from the non-genetically modified maize plants except for
showing resistance to certain Coleopteran insects, such as
Western corn rootworm, and certain Lepidopteran insects such as
European corn borer and showing tolerance when glufosinate and
glyphosate herbicides were applied, traits due to the genetic
modifications.
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
No risks to human and animal health or the environment from
the deliberate release of genetically modified 59122x1507xNK603
maize, resistant to certain Coleopteran and Lepidopteran insects
and tolerant to glufosinate and glyphosate herbicides, are
expected, as per information contained in the environmental risk
assessment included in the notification.
Brief description of any measures taken for the management of
risks:
The shedding of pollen from the genetically modified plants
will be controlled by maintaining a 200-meter isolation distance
with any other non-experimental maize crop. In addition, the
trial site will be surrounded by four border rows of
conventional maize of a similar relative maturity that will be
also destroyed at the end of the release.
Seed dispersal of individual kernels does not generally occur.
They are fixed on a cob and enclosed in many husks that protect
the seeds from outside contact. When a few seeds need to be
collected for analysis; this will be done by sampling the whole
ear and unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by
application of a non-selective herbicide, other than glufosinate
and glyphosate, or by mechanical destruction and incorporation
into the soil.
At the end of the release, all remaining plant matter that has
not been harvested for analyses will be destroyed by chopping
and incorporating into the soil. No plant or plant product
coming from the trials will enter the food or feed chains.
Volunteer maize will be monitored during the following year in
order to ensure their destruction, if needed.
No commercial maize will be cultivated in the trial site the
following year.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Not applicable to this release.
Final report
-
European
Commission administrative information
Consent given by the Competent
Authority: Not Known |
